Market Cap
$173.41 M
-$1.84 M-1.05%
2 min ago
Summary
- As of February 26, 2025, PLX market capitalization is $173.41 million, with a fall of -$1.84 million (-1.05%) during the most recent trading day.
- Over the past year, PLX market cap has increased by +$66.17 million (+61.70%).
- PLX market cap is now -94.22% below its all-time high of $3.00 billion.
Performance
PLX Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Related metrics
Market Cap Formula
Market Cap = Price ✕ Shares Outstanding
PLX Market Cap Trends
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
|---|---|---|---|---|
| todaytoday | -1.1% | -1.1% | 0.0% | -1.2% |
| 1 m1 month | -7.3% | -7.3% | - | -8.2% |
| 3 m3 months | +35.5% | +35.5% | - | +42.7% |
| 6 m6 months | +156.3% | +156.0% | - | +115.4% |
| ytdytd | +25.3% | +25.3% | - | +30.0% |
| 1 y1 year | +61.7% | +60.2% | +0.9% | +38.0% |
| 5 y5 years | +229.2% | -33.7% | +396.2% | +58.3% |
PLX Market Cap Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -12.8% | $161 M | +7.5% | |
| 3 m | 3-month | $199 M | -12.8% | $119 M | +45.4% |
| 6 m | 6-month | $199 M | -12.8% | $67 M | +159.0% |
| 1 y | 1-year | $199 M | -12.8% | $67 M | +159.0% |
| 3 y | 3-year | $220 M | -21.1% | $38 M | +358.6% |
| 5 y | 5-year | $282 M | -38.6% | $31 M | +456.5% |
| alltime | all time | $3.00 B | -94.2% | $249 K | >+9999.0% |
Protalix BioTherapeutics Market Cap History
| Date | Value |
|---|---|
| 2025 | $173.41 M(+25.3%) |
| 2024 | $138.43 M(+0.9%) |
| 2023 | $137.15 M(+86.1%) |
| 2022 | $73.69 M(+94.9%) |
| 2021 | $37.81 M(-70.0%) |
| 2020 | $126.20 M(+159.3%) |
| 2019 | $48.67 M(+5.8%) |
| 2018 | $46.00 M(-51.5%) |
| 2017 | $94.86 M(+69.8%) |
| 2016 | $55.86 M(-45.1%) |
| 2015 | $101.80 M(-40.9%) |
| 2014 | $172.23 M(-52.6%) |
| 2013 | $363.68 M(-25.0%) |
| 2012 | $485.21 M(+14.9%) |
| Date | Value |
|---|---|
| 2011 | $422.16 M(-47.7%) |
| 2010 | $806.79 M(+50.8%) |
| 2009 | $535.17 M(+283.1%) |
| 2008 | $139.71 M(-45.8%) |
| 2007 | $257.63 M(-75.0%) |
| 2006 | $1.03 B(+4064.1%) |
| 2005 | $24.78 M(+4142.7%) |
| 2004 | $584.00 K(-50.0%) |
| 2003 | $1.17 M(+263.6%) |
| 2002 | $321.20 K(-52.2%) |
| 2001 | $671.60 K(-8.9%) |
| 2000 | $736.88 K(-79.9%) |
| 1999 | $3.67 M(-35.7%) |
| 1998 | $5.71 M |
FAQ
- What is Protalix BioTherapeutics market capitalization?
- What is the all time high market cap for Protalix BioTherapeutics?
- What is PLX market capitalization year-to-date change?
- What is Protalix BioTherapeutics market cap year-on-year change?
What is Protalix BioTherapeutics market capitalization?
The current market cap of PLX is $173.41 M
What is the all time high market cap for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high market capitalization is $3.00 B
What is PLX market capitalization year-to-date change?
Protalix BioTherapeutics market capitalization has changed by +$34.98 M (+25.27%) since the beginning of the year
What is Protalix BioTherapeutics market cap year-on-year change?
Over the past year, PLX market capitalization has changed by +$66.17 M (+61.70%)